NIH revises funding to avoid studies with conflicts of interest

After coming under fire for funding research projects with clear conflicts of interest behind those conducting them, the National Institutes of Health has revised how it will fund future studies.

NIH released a report outlining new steps to “safeguard the integrity of its research and its reputation,” The New York Times reported. The agency will evaluate all current research projects for conflicts of interest among private donors that have given support to the project. Institute directors will report their findings to NIH Director Francis Collins, MD, PhD, in 2019.

The changes come six months after NIH halted a study that focused on health effects of moderate drinking. The study was partly funded by the alcohol industry, a fact that was met with criticism.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.